Active Ingredient Cagrilintide lyophilized peptide (2.5mg, 5mg, 10mg) Strength Tier Research-grade only Time to Results Not applicable (research use) Sun Sensitivity Not applicable research peptide Regulatory Status Research use only not for human consumption Cycling / Off Period Per study protocol not for human cycling Best For Licensed laboratory researchers studying amylin-analogue pharmacology, satiety signaling, and appetite-regulation pathways in controlled in-vitro or preclinical settings
Bloodbrain barrier permeability was assessed in azoxymethane (AOM)-treated mice at 6, 12, and 18 h post-injection via Evans blue extravasation
Impaired BBB integrity, such as the loss or degeneration of pericytes, disturbs regional CBF, disrupting the delicate balance required for optimal neural function [4,5,6]
The prescribed dose is divided by that concentration to calculate the injection volume
The peptide amount stays the same